Trust Signals
This page cites USP monographs, FDA drug labeling databases, and peer-reviewed pharmacology literature. Every specific claim is sourced or explicitly qualified. No affiliate relationships alter our sourcing recommendations. We flag where evidence is weak and where peptide users commonly make sourcing errors that create real safety risk.
Key Takeaways
Direct Answer: Where to Buy Bacteriostatic Water
Buy bacteriostatic water from a licensed compounding pharmacy, a USP-compliant research-grade supplier, or a retail pharmacy (with or without prescription depending on state and context). The supplier must provide a lot-specific Certificate of Analysis confirming 0.9% benzyl alcohol, endotoxins below 0.25 EU/mL, and sterility per USP standards. Price is not a reliable quality proxy; documentation is.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of Contents
- What exactly is bacteriostatic water and why does the formulation matter?
- Where can I buy bacteriostatic water: channel-by-channel breakdown
- Evidence ledger: what we actually know about BWFI safety and utility
- How do I verify a COA and read a label: operational literacy
- What most pages get wrong about bacteriostatic water
- The chemistry behind the rules: why benzyl alcohol and why 0.9%
- Head-to-head: BWFI vs sterile water vs bacteriostatic saline
- Reconstitution and volume guide for common peptide vials
- Stability, storage, and failure modes
- FAQ
- Sources
What Exactly Is Bacteriostatic Water and Why Does the Formulation Matter?
Bacteriostatic water for injection (BWFI) is sterile water to which 0.9% benzyl alcohol has been added as an antimicrobial preservative. The USP monograph for Bacteriostatic Water for Injection specifies that benzyl alcohol content must fall between 0.88% and 0.92% (w/v). It is prepared, sealed, and tested to the same sterility, particulate matter, and endotoxin standards as any parenteral product.
The word "bacteriostatic" describes the mechanism: benzyl alcohol inhibits bacterial replication but does not sterilize a contaminated solution. The initial fill is sterile; the preservative then defends that sterility across multiple punctures. This is why BWFI exists: it enables multi-dose access from a single vial, which is the standard workflow for peptide reconstitution where a researcher or clinician draws from the same vial over days or weeks.
Without the preservative, every needle entry into a vial is a contamination event waiting to express itself at body temperature. Sterile water for injection, sold without preservative, is a single-use product for that reason.
Where Can I Buy Bacteriostatic Water: Channel-by-Channel Breakdown
| Channel | Typical price (30 mL vial) | Prescription required? | COA available? | Best for | Watch out for |
|---|---|---|---|---|---|
| Retail pharmacy (chain or independent) | $8-20 | Sometimes; varies by state and pharmacist discretion | Manufacturer insert; lot traceable via NDC | Confirmed USP compliance, brand accountability | May not stock routinely; may require Rx |
| Compounding pharmacy (503A/503B) | $10-30 | Usually yes for clinical use; varies | Lot-specific COA standard | Clinical peptide protocols with prescriber oversight | 503A batches are patient-specific; 503B outsourcing facilities offer larger lot runs |
| Licensed research supplier (US-based) | $6-18 | No (sold as research reagent) | Should provide; demand it before ordering | Research use; bulk ordering | Quality varies widely; always request COA with endotoxin data |
| Online general marketplace (Amazon, eBay) | $5-15 | No | Rarely provided or verifiable | Not recommended for injection use | No lot traceability, no independent testing, counterfeit risk |
| Veterinary supplier | $8-18 | No in most states | Variable | Legitimate if sourced from known veterinary pharma brands | Some vet-grade products are USP-compliant; some are not; confirm the label |
Practical hierarchy: For any use involving human injection, the order of preference is: compounding pharmacy with prescriber oversight, then a licensed research supplier with a full lot-specific COA, then a retail pharmacy. General online marketplaces are not appropriate sources for injectable-grade BWFI regardless of price.
Evidence Ledger: What We Actually Know About BWFI Safety and Utility
| Claim | Best evidence type | Direction | Confidence |
|---|---|---|---|
| 0.9% benzyl alcohol inhibits bacterial growth in aqueous solution | USP efficacy testing standard; antimicrobial pharmacology literature | Positive (inhibitory) | High |
| BWFI is safe for adult subcutaneous or intramuscular use at typical peptide volumes | Decades of clinical use; FDA-approved multi-dose injectables use benzyl alcohol at same concentration | Positive (safe in adults) | High |
| Benzyl alcohol causes "gasping syndrome" and toxicity in neonates at high doses | FDA safety communication (1982); case series in neonatal ICU literature | Negative (harmful in neonates) | High |
| 28-day in-use window after first puncture is sufficient for safety | USP guidance; manufacturer labeling; derived from preservative efficacy data | Supportive (28 days reasonable) | Moderate (no large prospective human trial; derived from antimicrobial standards) |
| BWFI sourced from unverified online suppliers meets USP endotoxin limits | No independent data; anecdotal reports of product failures exist | Unknown / unreliable | Very Low |
| Benzyl alcohol degrades peptide bonds in reconstituted peptides over time | Mechanistic plausibility; limited in-vitro stability studies for specific peptides | Possible (depends on peptide and storage duration) | Low (peptide-specific; not generalizable) |
| BWFI is superior to sterile saline for peptide reconstitution solubility | Formulation chemistry principles; manufacturer recommendations for specific peptides | Context-dependent | Moderate (ionic strength matters for some peptides; not universal) |
How Do I Verify a COA and Read a Label: Operational Literacy
What a legitimate COA must contain:
- Product name: Bacteriostatic Water for Injection, USP (the "USP" designation is not cosmetic; it means the batch was tested to that monograph)
- Lot number: must match the lot printed on the vial
- Benzyl alcohol assay: 0.88% to 0.92% w/v. Values outside this range indicate non-conformance
- Endotoxin: reported in EU/mL with a passing limit of less than 0.25 EU/mL per USP <85> LAL method
- Sterility: "Pass" per USP <71> sterility testing
- Particulate matter: per USP <788> (visible and sub-visible particles)
- pH: typically 4.5 to 7.0
- Testing laboratory: should be ISO 17025 accredited or an FDA-registered facility
Red flags on a COA:
- No lot number or lot number does not match the vial
- Missing endotoxin data (the most commonly omitted and most safety-critical test)
- Testing lab name is not searchable or ISO accreditation cannot be verified
- COA is undated or shows a date after the expiration date
- Benzyl alcohol listed as "NF" grade rather than "USP" on a product marketed for injection
Label literacy: A compliant label must state the preservative and its concentration ("benzyl alcohol 0.9% as preservative"), the route (for injection), lot number, expiration date, storage conditions, manufacturer name and address, and the FDA-required "Not for use in newborns" warning. If the label omits the "Not for use in newborns" line, the product does not meet current FDA labeling requirements for BWFI.
What Most Pages Get Wrong About Bacteriostatic Water
1. Conflating "sterile" with "endotoxin-free." A product can pass a sterility test (no viable organisms cultured) and still contain dangerously high endotoxin (lipopolysaccharide from gram-negative bacteria killed during manufacturing). Endotoxin causes fever, chills, and in severe cases septic shock even without live organisms. This is why the LAL test is a separate, required test. Most consumer-facing BWFI pages never mention endotoxin at all.
2. Claiming BWFI is "good indefinitely" after reconstitution because it contains a preservative. The 28-day in-use window applies to the BWFI vial itself. Once a peptide is reconstituted in BWFI, the peptide's own stability becomes the limiting factor, which is often shorter and is peptide-specific and temperature-dependent. BWFI does not extend peptide shelf life; it just makes multi-dose access safer than sterile water.
3. Recommending bacteriostatic saline and BWFI interchangeably. They are different. Bacteriostatic saline adds 0.9% sodium chloride and 0.9% benzyl alcohol. For peptides where ionic strength affects solubility or aggregation, this matters. Always follow the specific reconstitution guidance for the peptide in question.
4. Ignoring benzyl alcohol compatibility with specific peptides. Benzyl alcohol at 0.9% can, over time, cause degradation of certain peptide bonds in susceptible sequences. This is not a universal problem and the clinical significance at typical reconstituted storage durations (a few weeks refrigerated) is debated, but it is a real formulation chemistry consideration that no commodity page discusses.
The Chemistry Behind the Rules: Why Benzyl Alcohol and Why 0.9%
Benzyl alcohol (C6H5CH2OH) is an aromatic alcohol. Its antimicrobial mechanism involves disruption of the bacterial cell membrane through interaction with lipid bilayer components, reducing membrane integrity and inhibiting active transport. It is effective against a broad range of gram-positive and gram-negative organisms at the concentrations used in BWFI.
The 0.9% concentration is not arbitrary. USP antimicrobial effectiveness testing (USP <51>) requires that preservatives in injectable products meet defined log-reduction criteria for organisms including Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Candida albicans over specified time intervals. 0.9% benzyl alcohol meets these criteria in aqueous solution. Lower concentrations may fail the test; higher concentrations increase local tissue irritation on injection and increase the total benzyl alcohol load per dose.
Why benzyl alcohol degrades at elevated temperature: Benzyl alcohol oxidizes to benzaldehyde and then to benzoic acid over time, particularly in the presence of heat and dissolved oxygen. This is why BWFI has an expiration date and why storing opened vials at refrigerator temperature (2-8 degrees Celsius) rather than room temperature slows this degradation. Benzoic acid at high concentrations is more irritating and less effective as a preservative. Practically, for vials used within 28 days of opening, this degradation is minor, but it is the chemical reason storage temperature is not optional.
Why not freezing: Ice crystal formation can stress the rubber stopper-vial seal and disrupt the crimp seal integrity. It does not destroy benzyl alcohol chemically, but it introduces a physical sterility risk. Thawing and refreezing cycles compound this risk.
Head-to-Head: BWFI vs Sterile Water vs Bacteriostatic Saline
| Property | BWFI (0.9% benzyl alcohol) | Sterile Water for Injection (SWFI) | Bacteriostatic Saline (0.9% NaCl + 0.9% benzyl alcohol) |
|---|---|---|---|
| Multi-dose safe | Yes | No (single use) | Yes |
| Ionic strength | Near zero (hypotonic) | Near zero (hypotonic) | Isotonic (~308 mOsm/L) |
| Affects peptide solubility | Minimal (no salt effect) | Minimal | Can reduce solubility of some peptides (salting-out effect) |
| Safe in neonates | No (benzyl alcohol) | Yes (use single-use vials) | No (benzyl alcohol) |
| Standard for peptide reconstitution | Yes (most protocols) | Acceptable if single-dose | Sometimes; peptide-dependent |
| Available OTC | Yes (research grade) | Yes (research grade) | Yes (research grade) |
| Where BWFI loses | N/A | SWFI wins when benzyl alcohol is contraindicated or when peptide is benzyl-alcohol-sensitive | Bac saline wins when isotonicity is specifically required by the formulation |
Reconstitution and Volume Guide for Common Peptide Vials
The math for reconstitution is simple and getting it wrong produces dosing errors that are multiples of intent. The formula: divide the volume of BWFI added (in mL) by the peptide mass in the vial (in mg) to get concentration in mg/mL. Then calculate your draw volume as dose (mg) divided by concentration (mg/mL).
| Peptide vial size | BWFI added | Resulting concentration | Volume for 1 mg dose | Volume for 0.5 mg dose |
|---|---|---|---|---|
| 5 mg | 1 mL (100 units on 1 mL syringe) | 5 mg/mL | 0.20 mL (20 units) | 0.10 mL (10 units) |
| 5 mg | 2 mL | 2.5 mg/mL | 0.40 mL (40 units) | 0.20 mL (20 units) |
| 10 mg | 2 mL | 5 mg/mL | 0.20 mL (20 units) | 0.10 mL (10 units) |
| 10 mg | 10 mL | 1 mg/mL | 1.00 mL (100 units) | 0.50 mL (50 units) |
Stability, Storage, and Failure Modes
Unopened vials: Store at controlled room temperature (15-30 degrees Celsius), away from light and humidity, until the printed expiration date. Refrigeration is acceptable but not required.
After first puncture: Refrigerate at 2-8 degrees Celsius. Use within 28 days. Mark the opening date on the vial with a marker. This is not a conservative suggestion; it is the standard derived from preservative efficacy testing timelines.
What degradation looks like: Discard the vial if you observe any of the following before the 28-day window closes: visible particulates (cloudiness, floating matter, color change from clear), a hissing sound when re-entering the vial (pressure change suggesting seal compromise), or visible rubber coring (small black fragments from repeated needle puncture). Coring risk increases with larger needle gauges; use 25 to 27 gauge needles when drawing BWFI.
Reconstituted peptide stability is separate: The peptide's amino acid sequence, disulfide bond content, and concentration determine how long the reconstituted solution remains potent. BWFI preserves sterility; it does not preserve peptide potency. Most lyophilized peptides reconstituted in BWFI and stored at 2-8 degrees Celsius are considered stable for roughly 30 days, but this varies by peptide and most figures come from manufacturer estimates rather than published stability studies. For any peptide where reconstituted stability data matter, ask the manufacturer for their specific stability profile data.
FAQ
Where can I buy bacteriostatic water without a prescription?
Bacteriostatic water is not a controlled substance and does not legally require a prescription in the United States when sold as a laboratory or research reagent. It is available from compounding pharmacies, licensed peptide/research suppliers, and some retail pharmacies. However, a pharmacy may still require a prescription if dispensing it for clinical injection use. Verify the supplier's COA and USP compliance before purchasing.
What is the difference between bacteriostatic water and sterile water for injection?
Bacteriostatic water for injection (BWFI) contains 0.9% benzyl alcohol as a preservative, inhibiting bacterial growth and allowing multi-dose use. Sterile water for injection (SWFI) contains no preservative and is intended for single use only. Using SWFI in a multi-dose vial introduces contamination risk with each subsequent draw. BWFI is the standard diluent for peptide reconstitution precisely because multi-dose access is the norm.
Is bacteriostatic water the same as saline or sodium chloride?
No. Bacteriostatic saline (0.9% NaCl + 0.9% benzyl alcohol) and bacteriostatic water (water + 0.9% benzyl alcohol, no salt) are different products. Some peptides are sensitive to ionic strength; adding salt to a solution that does not need it can affect solubility. Always confirm which diluent the manufacturer or prescriber specifies.
How do I verify that bacteriostatic water is pharmaceutical grade?
Request a Certificate of Analysis (COA) showing: water meets USP Sterile Water for Injection standards, benzyl alcohol concentration between 0.88% and 0.92%, endotoxin below 0.25 EU/mL by USP <85> LAL test, particulate matter within USP <788> limits, and pH 4.5 to 7.0. A legitimate supplier provides lot-specific COAs traceable to an ISO-accredited lab.
Can I use tap water or distilled water instead of bacteriostatic water?
No, not for injection. Tap water contains chloramines, minerals, and microorganisms. Distilled water lacks sterility assurance and endotoxin testing. Neither meets USP standards for injectable use. Using either for peptide reconstitution intended for injection creates serious infection and endotoxin fever risk.
How long does bacteriostatic water last once opened?
USP and most manufacturer guidelines suggest using opened BWFI within 28 days when stored at 2-8 degrees Celsius and accessed with sterile technique each time. The benzyl alcohol preservative inhibits but does not sterilize; repeated needle punctures eventually introduce particulates and risk. Discard if you see visible particles, cloudiness, or discoloration regardless of date.
What vial sizes are available and which should I order?
BWFI is commonly available in 30 mL multi-dose vials from research suppliers, and in 10 mL, 20 mL, or 30 mL from pharmacies. For typical peptide reconstitution (1 mg peptide in 1-2 mL water), a single 30 mL vial supports many reconstitutions. Order only what you will use within 28 days of first puncture to minimize contamination risk.
Is benzyl alcohol in bacteriostatic water safe?
At 0.9% concentration, benzyl alcohol is well-tolerated in adults at typical peptide injection volumes. The FDA has documented "gasping syndrome" in neonates from high-dose benzyl alcohol exposure (above 99 mg/kg/day), making BWFI contraindicated in neonates. For adults receiving subcutaneous peptide doses, the benzyl alcohol load is far below harmful thresholds.
Can I order bacteriostatic water online?
Yes. Several licensed research chemical suppliers and compounding pharmacies ship BWFI in the US. Prioritize suppliers who provide lot-specific COAs, list an ISO-accredited testing lab, and do not bundle it exclusively with unrelated research chemicals in ways that suggest cut-rate sourcing. Avoid products sold without any purity documentation.
What should a bacteriostatic water label legally include?
A compliant label should state: Bacteriostatic Water for Injection, USP; benzyl alcohol 0.9% as preservative; lot number; expiration date; storage conditions; manufacturer name and address; and "not for use in newborns" warning per FDA guidance. Absence of any of these elements is a quality red flag.
Does bacteriostatic water need to be refrigerated?
Unopened vials may be stored at controlled room temperature (15-30 degrees Celsius) per most manufacturers' specifications. Once opened, storage at 2-8 degrees Celsius is recommended to slow any potential microbial growth and slow benzyl alcohol off-gassing. Do not freeze; freezing can crack the vial seal and compromise sterility.
Sources
- United States Pharmacopeia. Bacteriostatic Water for Injection monograph. USP-NF. Current edition.
- United States Pharmacopeia. <51> Antimicrobial Effectiveness Testing. USP-NF.
- United States Pharmacopeia. <71> Sterility Tests. USP-NF.
- United States Pharmacopeia. <85> Bacterial Endotoxins Test. USP-NF.
- United States Pharmacopeia. <788> Particulate Matter in Injections. USP-NF.
- FDA. "Benzyl Alcohol May Be Toxic to Newborns." FDA Drug Bulletin, 1982. (Original FDA safety communication documenting gasping syndrome in neonates.)
- FDA. Drug Labeling Requirements for Benzyl Alcohol-Containing Injectables. FDA guidance documents and approved labeling archives.
- Gershanik J, Boecler B, Ensley H, McCloskey S, George W. "The gasping syndrome and benzyl alcohol poisoning." New England Journal of Medicine. 1982;307(22):1384-1388.
- Akers MJ. Parenteral Quality Control: Sterility, Pyrogen, Particulate, and Package Integrity Testing. 3rd ed. Marcel Dekker; 2002.
- FDA. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. 1999.
- FDA. Current Good Manufacturing Practice for Finished Pharmaceuticals. 21 CFR Part 211.
- Strickley RG. "Solubilizing Excipients in Oral and Injectable Formulations." Pharmaceutical Research. 2004;21(2):201-230. (Discusses benzyl alcohol as a solubilizing and antimicrobial excipient.)
Footer Disclaimers
Platform: FormBlends is an informational and commercial platform. Content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a licensed healthcare provider before using any injectable product or research compound.
Research Compound: Bacteriostatic water described on this page in the context of research supplier sourcing is sold as a research reagent. Its use in human injection outside of a clinical setting with appropriate prescriber oversight may not comply with applicable regulations. FormBlends does not condone unsupervised human use of injectable compounds.
Results: Individual results from any protocol involving reconstituted peptides vary based on numerous biological, procedural, and sourcing factors. No outcome claims are made or implied on this page.
Trademark: All product names, brand names, and trademarks mentioned on this page are the property of their respective owners. Their mention does not imply endorsement or affiliation with FormBlends.